Total Payments
$4,186
2024 Payments
$1,638
Companies
21
Transactions
192
Medicare Patients
158
Medicare Billing
$41,707
Payment Breakdown by Category
Food & Beverage$4,139 (98.9%)
Education$46.91 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,139 | 191 | 98.9% |
| Education | $46.91 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $761.37 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $532.28 | 26 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $522.85 | 20 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $435.68 | 17 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $307.73 | 15 | $0 (2024) |
| ABBVIE INC. | $262.42 | 16 | $0 (2024) |
| Alkermes, Inc. | $224.83 | 7 | $0 (2019) |
| ITI, Inc. | $198.13 | 8 | $0 (2023) |
| Lundbeck LLC | $191.97 | 9 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $171.41 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,638 | 86 | Otsuka America Pharmaceutical, Inc. ($262.19) |
| 2023 | $1,182 | 57 | Otsuka America Pharmaceutical, Inc. ($240.92) |
| 2022 | $145.19 | 7 | Otsuka America Pharmaceutical, Inc. ($41.39) |
| 2021 | $822.07 | 30 | Neurocrine Biosciences, Inc. ($169.41) |
| 2020 | $60.90 | 3 | Otsuka America Pharmaceutical, Inc. ($38.58) |
| 2019 | $85.36 | 5 | Alkermes, Inc. ($74.53) |
| 2018 | $252.54 | 4 | Alkermes, Inc. ($150.30) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $24.07 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Central Nervous System | ||||||
| 12/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $22.81 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.14 | General |
| Category: Neuropsychiatry | ||||||
| 10/30/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: Neuroscience | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Neuropsychiatry | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Neuropsychiatry | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/01/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Neurology | ||||||
| 09/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Neuropsychiatry | ||||||
| 09/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Neuroscience | ||||||
| 09/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: PSYCHIATRY | ||||||
| 08/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 33 | 147 | $23,120 | $11,244 |
| 2022 | 2 | 49 | 205 | $32,925 | $15,779 |
| 2021 | 4 | 76 | 199 | $35,615 | $14,684 |
Total Patients
158
Total Services
551
Medicare Billing
$41,707
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 85 | $17,850 | $7,954 | 44.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 15 | 62 | $5,270 | $3,290 | 62.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 124 | $26,040 | $11,428 | 43.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 19 | 81 | $6,885 | $4,352 | 63.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 101 | $21,210 | $8,381 | 39.5% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 17 | 55 | $4,675 | $2,603 | 55.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 19 | 19 | $5,890 | $2,322 | 39.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 24 | $3,840 | $1,377 | 35.9% |
About Dr. Lauren Wilson, M.D
Dr. Lauren Wilson, M.D is a Psychiatry healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2016. The National Provider Identifier (NPI) number assigned to this provider is 1861847113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lauren Wilson, M.D has received a total of $4,186 in payments from pharmaceutical and medical device companies, with $1,638 received in 2024. These payments were reported across 192 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,139).
As a Medicare-enrolled provider, Wilson has provided services to 158 Medicare beneficiaries, totaling 551 services with total Medicare billing of $41,707. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Austin, TX
- Active Since 04/24/2016
- Last Updated 07/23/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1861847113
Products in Payments
- REXULTI (Drug) $567.98
- INGREZZA (Drug) $522.85
- INVEGA SUSTENNA (Drug) $506.30
- TRINTELLIX (Drug) $307.73
- CAPLYTA (Drug) $304.63
- ABILIFY MAINTENA (Drug) $275.60
- VRAYLAR (Drug) $262.42
- Austedo XR (Drug) $199.90
- AUSTEDO (Drug) $192.12
- Aristada 441 mg (Drug) $150.30
- Azstarys (Drug) $132.48
- LATUDA (Drug) $112.20
- FANAPT (Drug) $93.69
- HETLIOZ (Drug) $77.72
- ARISTADA (Drug) $74.53
- COBENFY (Drug) $46.88
- Qelbree (Drug) $46.11
- PERSERIS (Drug) $44.11
- UZEDY (Drug) $43.66
- NUEDEXTA (Drug) $37.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Austin
Dr. Donald Garcia, Md, MD
Psychiatry — Payments: $4.0M
Psychiatry $4.0M
Dr. Arvinder Pal Walia, M.d, M.D
Psychiatry — Payments: $2.7M
Psychiatry $2.7M
Charles Nemeroff, Md Phd, MD PHD
Psychiatry — Payments: $400,808
Psychiatry $400,808
Dr. Divyansu Patel, M.d, M.D
Psychiatry — Payments: $319,461
Psychiatry $319,461
Frank Floca, Md, MD
Psychiatry — Payments: $99,177
Psychiatry $99,177
Dr. Charles Sweet, M.d., M.p.h, M.D., M.P.H
Psychiatry — Payments: $88,371
Psychiatry $88,371